Keros Therapeutics

KROS • NASDAQ • Stock Fundamentals

Keros Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jasbir S. Seehra, with a market cap of $222.3M.

Market Cap$222.3M

Employees141.0

CEOJasbir S. Seehra

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Keros Therapeutics

Keros Therapeutics (KROS) has a market capitalization of $222.3M and trades on NASDAQ.

Keros Therapeutics has approximately 141 employees.